PDE5A and systemic lupus erythematosus: There are effective, evidence-based therapeutic options for treating both PAH itself with vasodilator therapy (e.g., a prostanoid, ERA, or PDE-5 inhibitor) and the SLE flares leading to PAH exacerbation with immunomodulators (e.g., high-dose corticosteroids and cyclophosphamide).